Keybanc raises Acadia Healthcare price target to $40
Keybanc analyst Matthew Gillmor maintained an Overweight rating on Acadia Healthcare Co and raised the price target from $30 to $40, signaling a positive outlook for the stock.
*this image is generated using AI for illustrative purposes only.
Keybanc analyst Matthew Gillmor has raised the price target for Acadia Healthcare Co to $40 while maintaining an Overweight rating on the stock. The adjustment increases the previous target of $30, reflecting a more optimistic view on the company's performance potential.
Rating and Price Target Details
The analyst's decision to maintain the Overweight rating indicates confidence that Acadia Healthcare Co will outperform the broader market or its sector peers. The new price target of $40 represents a significant increase from the prior $30 level set by the firm.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $30 |
| New Price Target | $40 |
What specific operational metrics or growth drivers does Keybanc expect will fuel Acadia Healthcare's performance to reach the new $40 price target?
How might Acadia Healthcare's valuation compare to its sector peers if the stock approaches the revised $40 target?
Could this price target increase signal a broader bullish trend for the behavioral healthcare sector?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
